4//SEC Filing
GARNICK MARC B 4
Accession 0001033025-03-000003
CIK 0001033025other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 6:39 PM ET
Size
10.1 KB
Accession
0001033025-03-000003
Insider Transaction Report
Form 4
GARNICK MARC B
EVP and Chief Medical Officer
Transactions
- Gift
Common Stock, par value $.01 per share
2003-09-17−36,000→ 407,722 total - Award
Stock Option (Right to Buy)
2003-11-13+87,500→ 87,500 totalExercise: $6.68From: 2003-12-13Exp: 2013-11-13→ Common Stock, par value $.01 per share (87,500 underlying)
Holdings
- 25,270(indirect: By Trust)
Common Stock, par value $.01 per share
Footnotes (3)
- [F1]These shares were previously reported as directly beneficially owned but were contributed to a grantor retained annuity trust on 09/17/2003.
- [F2]The term of the option is ten years from the date of grant.
- [F3]These options vest and become exercisable in equal monthly installments over a three-year period. These options shall vest and become immediately exercisable in the event that the recipient is terminated in connection with a change of control of the Company.
Documents
Issuer
PRAECIS PHARMACEUTICALS INC
CIK 0001033025
Entity typeother
Related Parties
1- filerCIK 0001215549
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 6:39 PM ET
- Size
- 10.1 KB